Guardion health sciences, inc. (GHSI)

CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
Operating Activities
Net loss

-11,840

-10,878

-8,298

-8,061

-6,819

-7,767

-8,487

-7,923

-6,969

-5,305

-5,416

-4,973

-5,468

-5,748

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

432

477

282

284

290

295

293

236

176

118

63

72

67

60

0

0

0

Amortization of debt discount

-

250

0

0

0

-

-

-

-

-

-

-

-

431

0

0

0

Amortization of lease right

155

148

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest expense included in notes payable

-

0

0

0

0

-

0

0

-21

-

39

59

82

86

0

0

0

Stock-based compensation

389

378

489

783

873

1,595

2,349

2,581

2,606

1,932

1,135

815

883

787

0

0

0

Stock-based compensation - officer and director

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation – related parties

-

-

-

-

-

0

-13

75

125

183

495

556

799

982

0

0

0

Change in fair value of derivative warrants

-470

-292

0

0

0

-

-

-

-

-

-

-

-

575

0

0

0

Changes in operating assets and liabilities:
(Increase) decrease in -
Accounts receivable

15

50

4

6

-42

-44

-36

-21

5

20

3

0

0

0

0

0

0

Inventories

138

-47

-60

-93

120

203

203

210

39

17

18

74

8

13

0

0

0

Prepaid expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Deposits and prepaid expenses

-

-

-

-

-

-68

12

19

76

87

-1

-20

5

-14

0

0

0

Increase (decrease) in -
Accounts payable

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Customer deposit

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

102

-216

-33

-63

-121

50

51

39

84

0

0

0

Lease liability

149

140

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued and deferred rent costs

-

-

-

-

-

69

-2

-3

-43

-76

-67

-104

-61

-54

0

0

0

Net cash used in operating activities

-7,179

-6,030

-5,074

-4,243

-3,406

-4,173

-4,776

-4,804

-4,311

-3,403

0

0

0

-

-

-

-

Investing Activities
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Purchase of property and equipment

206

171

195

182

169

260

240

168

132

37

25

7

2

3

0

0

0

Purchase of intellectual property

-

-

-

-

-

50

50

50

50

0

0

0

0

-

-

-

-

Net cash used in investing activities

-206

-171

-195

-182

-169

-310

-290

-213

-177

-32

0

0

0

-

-

-

-

Financing Activities
Proceeds from issuance of preferred stock

-

-

-

-

-

0

0

2,005

2,405

3,105

3,205

1,700

1,845

1,145

0

0

0

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Proceeds from issuance of convertible notes

-

250

0

0

0

-

-

-

-

-

-

-

-

136

0

0

0

Proceeds from issuance of promissory notes - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

140

0

0

0

Proceeds from issuance of promissory notes

-

100

100

100

100

0

0

0

0

100

100

150

295

220

0

0

0

Payments on promissory note

-

-

-

-

-

0

25

135

135

149

138

35

165

151

0

0

0

Proceeds from exercise of warrants

3,690

171

169

146

46

16

1

1

1

0

0

0

0

-

-

-

-

Payments on line of credit

-

-

-

-

-

30

32

32

32

1

0

0

0

-

-

-

-

Deferred financing costs of IPO

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in due to related parties

-

-

-

-

-

-146

-44

-51

3

54

105

183

172

215

0

0

0

Net cash provided by financing activities

20,102

16,645

9,723

4,727

552

419

4,899

6,787

7,242

8,108

0

0

0

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Cash:
Net increase (decrease)

12,715

10,444

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease

-

-

-

-

-

-4,064

-167

1,768

2,753

4,672

879

19

459

48

0

0

0

Supplemental disclosure of cash flow information:
Cash paid for - Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Non-cash financing activities:
Fair value of warrants issued in connection with convertible notes

-

436

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Recording of lease asset and liability upon adoption of ASU 2016-02

-

721

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Reclass of prepaid costs to inventory

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclass of equipment sold from property and equipment to equipment held for sale

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of warrants issued in connection with promissory and convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

270

0

0

0

Beneficial conversion feature associated with promissory and convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

70

0

0

0